Gemma Rooney, PhD

TitleLicensing Officer
InstitutionUniversity of California San Francisco
DepartmentInnovation Ventures
Address600 16th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    As a Licensing Officer, Gemma is responsible for evaluating and managing new technologies, determining the patenting strategy, commercializing technologies through licensing and helping to negotiate the intellectual property terms in sponsored research agreements with industry partners. Gemma has been co-managing the OTM’s internship program since 2014, when she joined the OTM team.

    Gemma holds a Ph.D. in Neuroscience and Stem Cell Biology from the National University of Ireland, Galway, and a B.Sc. in Neuroscience from University College Cork, Ireland. She received postdoctoral training from the University of California, San Francisco and the Mayo Clinic College of Medicine. Her research focused on neurological applications of stem cell therapies. Gemma became very interested in translating science concepts into products that could improve patient health outcomes. Thus, transitioning to the field of technology transfer was a natural next step in her career. Gemma is motivated to apply her scientific expertise to help basic researchers and clinicians to bring their ideas, concepts and products into active patient use.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rooney GE, Goodwin AF, Depeille P, Sharir A, Schofield CM, Yeh E, Roose JP, Klein OD, Rauen KA, Weiss LA, Ullian EM. Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras Signaling in Costello Syndrome. J Neurosci. 2016 Jan 06; 36(1):142-52. PMID: 26740656; PMCID: PMC4701956.
    2. Krencik R, Hokanson KC, Narayan AR, Dvornik J, Rooney GE, Rauen KA, Weiss LA, Rowitch DH, Ullian EM. Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci Transl Med. 2015 May 06; 7(286):286ra66. PMID: 25947161; PMCID: PMC4474402.
    3. Madigan NN, Chen BK, Knight AM, Rooney GE, Sweeney E, Kinnavane L, Yaszemski MJ, Dockery P, O'Brien T, McMahon SS, Windebank AJ. Comparison of cellular architecture, axonal growth, and blood vessel formation through cell-loaded polymer scaffolds in the transected rat spinal cord. Tissue Eng Part A. 2014 Nov; 20(21-22):2985-97. PMID: 24854680; PMCID: PMC4229864.
    4. Donnelly EM, Madigan NN, Rooney GE, Knight A, Chen B, Ball B, Kinnavane L, Garcia Y, Dockery P, Fraher J, Strappe PM, Windebank AJ, O'Brien T, McMahon SS. Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord. Cytotherapy. 2012 Nov; 14(10):1235-44. PMID: 23066785.
      View in: PubMed
    5. Chen BK, Knight AM, Madigan NN, Gross L, Dadsetan M, Nesbitt JJ, Rooney GE, Currier BL, Yaszemski MJ, Spinner RJ, Windebank AJ. Comparison of polymer scaffolds in rat spinal cord: a step toward quantitative assessment of combinatorial approaches to spinal cord repair. Biomaterials. 2011 Nov; 32(32):8077-86. PMID: 21803415; PMCID: PMC3163757.
    6. Rooney GE, Knight AM, Madigan NN, Gross L, Chen B, Giraldo CV, Seo S, Nesbitt JJ, Dadsetan M, Yaszemski MJ, Windebank AJ. Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A. 2011 May; 17(9-10):1287-302. PMID: 21198413; PMCID: PMC3079174.
    7. Donnelly EM, Strappe PM, McGinley LM, Madigan NN, Geurts E, Rooney GE, Windebank AJ, Fraher J, Dockery P, O'Brien T, McMahon SS. Lentiviral vector-mediated knockdown of the NG2 [corrected] proteoglycan or expression of neurotrophin-3 promotes neurite outgrowth in a cell culture model of the glial scar. J Gene Med. 2010 Nov; 12(11):863-72. PMID: 21105148.
      View in: PubMed
    8. Moloney TC, Rooney GE, Barry FP, Howard L, Dowd E. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain. Brain Res. 2010 Nov 04; 1359:33-43. PMID: 20732313.
      View in: PubMed
    9. McMahon SS, Albermann S, Rooney GE, Shaw G, Garcia Y, Sweeney E, Hynes J, Dockery P, O'Brien T, Windebank AJ, Allsopp TE, Barry FP. Engraftment, migration and differentiation of neural stem cells in the rat spinal cord following contusion injury. Cytotherapy. 2010 May; 12(3):313-25. PMID: 20370348.
      View in: PubMed
    10. Rooney GE, McMahon SS, Ritter T, Garcia Y, Moran C, Madigan NN, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP. Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Tissue Eng Part A. 2009 Oct; 15(10):3049-59. PMID: 19335061.
      View in: PubMed
    11. Rooney GE, Endo T, Ameenuddin S, Chen B, Vaishya S, Gross L, Schiefer TK, Currier BL, Spinner RJ, Yaszemski MJ, Windebank AJ. Importance of the vasculature in cyst formation after spinal cord injury. J Neurosurg Spine. 2009 Oct; 11(4):432-7. PMID: 19929340; PMCID: PMC2981802.
    12. Olson HE, Rooney GE, Gross L, Nesbitt JJ, Galvin KE, Knight A, Chen B, Yaszemski MJ, Windebank AJ. Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A. 2009 Jul; 15(7):1797-805. PMID: 19191513; PMCID: PMC2792101.
    13. McMahon SS, Albermann S, Rooney GE, Moran C, Hynes J, Garcia Y, Dockery P, O'Brien T, Windebank AJ, Barry FP. Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury. J Anat. 2009 Sep; 215(3):267-79. PMID: 19558472; PMCID: PMC2750760.
    14. Rooney GE, Howard L, O'Brien T, Windebank AJ, Barry FP. Elevation of cAMP in mesenchymal stem cells transiently upregulates neural markers rather than inducing neural differentiation. Stem Cells Dev. 2009 Apr; 18(3):387-98. PMID: 18554089.
      View in: PubMed
    15. Krych AJ, Rooney GE, Chen B, Schermerhorn TC, Ameenuddin S, Gross L, Moore MJ, Currier BL, Spinner RJ, Friedman JA, Yaszemski MJ, Windebank AJ. Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater. 2009 Sep; 5(7):2551-9. PMID: 19409869; PMCID: PMC2731813.
    16. Rooney GE, Vaishya S, Ameenuddin S, Currier BL, Schiefer TK, Knight A, Chen B, Mishra PK, Spinner RJ, Macura SI, Yaszemski MJ, Windebank AJ. Rigid fixation of the spinal column improves scaffold alignment and prevents scoliosis in the transected rat spinal cord. Spine (Phila Pa 1976). 2008 Nov 15; 33(24):E914-9. PMID: 19011531; PMCID: PMC2773001.
    17. Rooney GE, Moran C, McMahon SS, Ritter T, Maenz M, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP. Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate. Tissue Eng Part A. 2008 May; 14(5):681-90. PMID: 18402551.
      View in: PubMed